Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan(National University of Singapore), Mark Muthiah(National University of Singapore), Daniel Q. Huang(National University Health System), Darren Jun Hao Tan(National University of Singapore), Christen En Ya Ong(National University of Singapore), Dan Yock Young(National University of Singapore), Jie Ning Yong(National University of Singapore), Nobuharu Tamaki(Musashino Red Cross Hospital), Zhen Yu Wong(Nottingham University Hospitals NHS Trust), Wen Hui Lim(National University of Singapore), Nicholas Syn(National University of Singapore), Mazen Noureddin, Jieling Xiao(National University of Singapore), Benjamin Koh(National University of Singapore), Elden Yen Hng Ong(National University of Singapore), Arun J. Sanyal(Virginia Commonwealth University), Jiong‐Wei Wang(National University of Singapore), Apichat Kaewdech(Prince of Songkla University), Cheng Han Ng(National University of Singapore), Nicholas Chew(National University Health System), Charlotte Hui Chung(National University of Singapore), Alfred Know(National University of Singapore), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Mohammad Shadab Siddiqui(Virginia Commonwealth University), Margaret Teng(National University of Singapore), Christos S. Mantzoros(Harvard University)
Cited by 123
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k